Cardiac death should be the primary endpoint for revascularization trials and meta-analyses. White HD. Eur Heart J 2021;42:4697-4698.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

White HD. Cardiac death should be the primary endpoint for revascularization trials and meta-analyses. Eur Heart J 2021;42:4697-4698.
PMID: 34545390